{"gene":"CDIN1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2013,"finding":"C15orf41 (CDIN1) is predicted to encode a novel restriction endonuclease that is a member of the Holliday junction resolvase family of proteins, based on detailed sequence similarity searches; homozygous missense mutations (p.L178Q and p.Y94C) in this gene cause congenital dyserythropoietic anemia type I.","method":"Whole genome sequencing, segregation analysis, and sequence similarity/structural bioinformatics","journal":"Haematologica","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction of endonuclease function, no in vitro enzymatic activity demonstrated; disease linkage is strong but mechanism is inferred","pmids":["23716552"],"is_preprint":false},{"year":2019,"finding":"CDIN1 endogenous protein localizes predominantly to the nucleus (with some cytosolic presence). The disease-associated mutation H230P in the nuclease domain reduces gene expression and protein level, while Y94S (in the DNA binding domain) causes a slight decrease in expression. Both mutations impair erythroid differentiation in K562 cells; H230P also causes increased S-phase accumulation.","method":"Immunofluorescence (subcellular localization), western blotting (protein levels), erythroid differentiation assay in K562 cells, cell cycle analysis","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple orthogonal methods (IF, WB, functional differentiation assay, cell cycle), single lab","pmids":["31191338"],"is_preprint":false},{"year":2020,"finding":"C15orf41 (CDIN1) forms a tight, near-stoichiometric complex with Codanin-1 (CDAN1), interacting with the C-terminal region of Codanin-1. Codanin-1 appears to sequester C15orf41 in the cytoplasm (analogous to its sequestration of ASF1), and Codanin-1 stabilizes C15orf41 protein levels.","method":"Co-immunoprecipitation, in vitro biochemical characterization, immunofluorescence, western blotting","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus in vitro characterization, replicated by independent labs (Swickley et al. 2020, Olijnik et al. 2020)","pmids":["32239177"],"is_preprint":false},{"year":2020,"finding":"Codanin-1 binds to and stabilizes C15orf41 (CDIN1) protein. Overexpression of Codanin-1 shifts C15orf41 localization from nucleus to cytoplasm. Phylogenetic co-loss analysis shows Codanin-1 and C15orf41 are eliminated in the exact same animal taxa, strongly suggesting a common pathway.","method":"Co-immunoprecipitation, overexpression with immunofluorescence, phylogenetic profiling analysis","journal":"BMC molecular and cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus localization shift experiment plus phylogenetic profiling, single lab","pmids":["32293259"],"is_preprint":false},{"year":2020,"finding":"CDIN1 and Codanin-1 form an obligate complex that is enriched in the nucleolus. C15orf41 (CDIN1) relies on Codanin-1 for its stability. This interaction was demonstrated in human cells by co-immunoprecipitation and immunofluorescence.","method":"Immunoprecipitation, immunofluorescence, western blotting","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal IP and co-localization, single lab, consistent with Shroff et al. 2020","pmids":["32518175"],"is_preprint":false},{"year":2021,"finding":"CDAN1 and CDIN1 proteins are enriched in nucleoli, which are structurally and functionally abnormal in CDA-I patient-derived erythroid cells. Erythroid cells from CDA-I patients (carrying mutations in CDAN1 or CDIN1) show delayed terminal erythroid differentiation, increased proliferation, and widespread changes in chromatin accessibility.","method":"Erythroid culture system, electron microscopy (heterochromatin morphology), immunofluorescence (nucleolar localization), ATAC-seq (chromatin accessibility), flow cytometry (differentiation)","journal":"Haematologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods with patient-derived cells; single lab but comprehensive","pmids":["33121234"],"is_preprint":false},{"year":2021,"finding":"Codanin-1 physically interacts with CDIN1, and this interaction is conserved; mutations in CDAN1 and CDIN1 result in CDA-I via a common mechanism, supported by Cdan1 being essential for primitive erythropoiesis in mouse models.","method":"Co-immunoprecipitation (physical interaction), mouse knockout model (Cdan1)","journal":"Current opinion in hematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — physical interaction confirmed by Co-IP (citing primary data), mouse model for pathway placement; review summarizing primary experimental findings","pmids":["35441598"],"is_preprint":false},{"year":2024,"finding":"CDAN1 dimerizes and assembles into cytosolic complexes with CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures show that CDAN1 engages ASF1 via two B-domains and two helices that mimic histone H3 binding, thereby sequestering and inhibiting ASF1 chaperone function. One CDAN1 can recruit two ASF1 molecules. ASF1A and ASF1B have different requirements for CDAN1 engagement. CDIN1 is a component of this cytosolic complex.","method":"Single-particle cryo-EM, biochemistry (pulldown, reconstitution), structural prediction, mutagenesis","journal":"bioRxiv (preprint)","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure plus biochemical reconstitution and mutagenesis; superseded by peer-reviewed publication (PMID:40091041)","pmids":["39149339"],"is_preprint":true},{"year":2025,"finding":"CDAN1 dimerizes and assembles into cytosolic complexes containing CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures reveal CDAN1 engages ASF1 through two B-domains and two helices mimicking histone H3, occupying all known ASF1 functional binding sites to sequester and inhibit ASF1 histone chaperoning. CDIN1 is part of this cytosolic complex. ASF1A and ASF1B differ in their requirements for CDAN1 engagement.","method":"Single-particle cryo-EM, biochemical reconstitution, structural predictions, pulldowns","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with biochemical reconstitution and multiple orthogonal methods in a single rigorous study","pmids":["40091041"],"is_preprint":false},{"year":2026,"finding":"CDIN1 and the C-terminus of Codanin-1 form a high-affinity heterodimeric complex with equimolar stoichiometry. CDA-I-associated mutations in either CDIN1 or Codanin-1 disrupt this interaction, suggesting disruption of the CDIN1-Codanin1 complex as a molecular mechanism underlying CDA-I. The essential interacting regions of both proteins were delineated.","method":"Biophysical techniques (complementary methods for affinity measurement and stoichiometry), structural analysis, functional mutation analysis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple complementary biophysical methods in one study with disease mutant functional validation; single lab","pmids":["41609415"],"is_preprint":false}],"current_model":"CDIN1 (C15orf41) encodes a predicted restriction endonuclease/Holliday junction resolvase that forms a high-affinity, near-stoichiometric heterodimeric complex with Codanin-1 (CDAN1) through the Codanin-1 C-terminus; Codanin-1 stabilizes CDIN1 and sequesters it in the cytoplasm as part of a larger cytosolic complex that also contains multiple copies of the histone H3-H4 chaperones ASF1A and ASF1B (which Codanin-1 inhibits by mimicking histone H3 and occupying all ASF1 binding sites); CDIN1 localizes predominantly to the nucleus and is enriched in nucleoli during erythropoiesis, and disease-associated mutations in either CDAN1 or CDIN1 disrupt the CDIN1-Codanin1 interaction and impair erythroid differentiation and chromatin organization, causing CDA-I."},"narrative":{"mechanistic_narrative":"CDIN1 (C15orf41) is a nuclear, nucleolus-enriched protein that functions as an obligate partner of Codanin-1 (CDAN1) in a pathway required for erythroid differentiation, and biallelic mutation of CDIN1 causes congenital dyserythropoietic anemia type I (CDA-I) [PMID:23716552, PMID:31191338]. Sequence and structural analysis place CDIN1 in the Holliday junction resolvase family of restriction endonucleases [PMID:23716552]. CDIN1 forms a high-affinity, near-stoichiometric heterodimer with the C-terminal region of Codanin-1; this interaction stabilizes CDIN1 protein levels and governs its localization, with Codanin-1 sequestering CDIN1 within larger cytosolic complexes [PMID:32239177, PMID:41609415]. These complexes also contain dimeric CDAN1 and multiple copies of the histone H3-H4 chaperones ASF1A/B, which CDAN1 engages and inhibits by mimicking histone H3 and occupying all ASF1 binding sites, placing the CDIN1-Codanin-1 module within histone chaperone regulation [PMID:40091041]. In patient-derived erythroid cells, CDAN1 and CDIN1 are enriched in nucleoli that are structurally abnormal, and loss of function delays terminal erythroid differentiation, increases proliferation, and broadly alters chromatin accessibility [PMID:33121234]. CDA-I-associated mutations in either CDIN1 or Codanin-1 disrupt the CDIN1-Codanin-1 interaction, defining loss of this complex as the shared molecular basis of the disease [PMID:41609415]. The catalytic activity predicted for CDIN1 has not been demonstrated enzymatically in the available corpus.","teleology":[{"year":2013,"claim":"Established CDIN1 as a disease gene and assigned a predicted molecular identity, framing the question of what biochemical function underlies CDA-I.","evidence":"Whole genome sequencing with segregation analysis and sequence/structural bioinformatics identifying homozygous missense mutations","pmids":["23716552"],"confidence":"Low","gaps":["Endonuclease/resolvase activity is purely computational with no in vitro enzymatic demonstration","No substrate identified","No mechanistic link between predicted nuclease function and erythropoiesis"]},{"year":2019,"claim":"Showed where CDIN1 acts and that disease mutations are functionally consequential, linking the protein to erythroid differentiation and cell cycle control.","evidence":"Immunofluorescence localization, western blot of mutant protein levels, and erythroid differentiation and cell cycle assays in K562 cells","pmids":["31191338"],"confidence":"Medium","gaps":["Mechanism connecting mutations to differentiation defect unresolved","Single cell-line model","No direct biochemical activity tested"]},{"year":2020,"claim":"Defined CDIN1's primary physical partner, revealing that CDIN1 is a Codanin-1-dependent protein whose stability and localization are controlled by complex formation.","evidence":"Reciprocal co-immunoprecipitation, in vitro characterization, overexpression-driven localization shifts, immunofluorescence, and phylogenetic co-loss profiling across multiple independent labs","pmids":["32239177","32293259","32518175"],"confidence":"High","gaps":["Functional consequence of nucleolar enrichment not defined","Whether CDIN1 has activity independent of Codanin-1 unknown","Interface residues not yet mapped at this stage"]},{"year":2021,"claim":"Connected the CDIN1-Codanin-1 complex to a cellular phenotype, showing nucleolar abnormalities and chromatin disorganization in patient erythroid cells and a common mechanism for CDAN1 and CDIN1 mutations.","evidence":"Patient-derived erythroid cultures, electron microscopy, immunofluorescence, ATAC-seq, flow cytometry, and Cdan1 mouse knockout","pmids":["33121234","35441598"],"confidence":"Medium","gaps":["Causal chain from complex loss to altered chromatin accessibility not established","CDIN1-specific knockout phenotype not separated from CDAN1","Direct role of CDIN1 in chromatin organization untested"]},{"year":2025,"claim":"Provided the structural context placing CDIN1 within a CDAN1-ASF1 cytosolic assembly that inhibits histone chaperone function by histone H3 mimicry.","evidence":"Single-particle cryo-EM with biochemical reconstitution, pulldowns, and mutagenesis (peer-reviewed; superseding the 2024 bioRxiv preprint)","pmids":["40091041","39149339"],"confidence":"High","gaps":["CDIN1's structural placement and role within the assembly not resolved at atomic level","Whether CDIN1 contributes to ASF1 inhibition unknown","No catalytic function assigned to CDIN1 in the complex"]},{"year":2026,"claim":"Quantified the CDIN1-Codanin-1 interaction and demonstrated that CDA-I mutations on either protein disrupt it, pinning the disease mechanism to loss of the heterodimer.","evidence":"Complementary biophysical affinity and stoichiometry measurements, structural analysis, and disease-mutant functional validation","pmids":["41609415"],"confidence":"High","gaps":["Downstream molecular event triggered by complex disruption unknown","Single lab","Does not establish enzymatic role of CDIN1"]},{"year":null,"claim":"The predicted endonuclease/resolvase catalytic activity of CDIN1 and its physiological substrate remain undemonstrated, leaving the link between its molecular activity and erythroid chromatin biology unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in vitro nuclease activity shown","No DNA or RNA substrate identified","Mechanistic role of CDIN1 within the CDAN1-ASF1 complex undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[4,5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,8]}],"pathway":[],"complexes":["CDIN1-Codanin-1 heterodimer","CDAN1-CDIN1-ASF1A/B cytosolic complex"],"partners":["CDAN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y2V0","full_name":"CDAN1-interacting nuclease 1","aliases":["Protein HH114"],"length_aa":281,"mass_kda":32.3,"function":"Plays a role in erythroid cell differentiation","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9Y2V0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CDIN1","classification":"Not Classified","n_dependent_lines":253,"n_total_lines":1208,"dependency_fraction":0.20943708609271522},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CDIN1","total_profiled":1310},"omim":[{"mim_id":"615631","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B","url":"https://www.omim.org/entry/615631"},{"mim_id":"615626","title":"CDAN1-INTERACTING NUCLEASE 1; CDIN1","url":"https://www.omim.org/entry/615626"},{"mim_id":"605064","title":"KINESIN FAMILY MEMBER 23; KIF23","url":"https://www.omim.org/entry/605064"},{"mim_id":"224120","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A","url":"https://www.omim.org/entry/224120"},{"mim_id":"105600","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa; CDAN3A","url":"https://www.omim.org/entry/105600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":73.6},{"tissue":"tongue","ntpm":32.2}],"url":"https://www.proteinatlas.org/search/CDIN1"},"hgnc":{"alias_symbol":["HH114","MGC11326","FLJ22851"],"prev_symbol":["C15orf41"]},"alphafold":{"accession":"Q9Y2V0","domains":[{"cath_id":"-","chopping":"61-151","consensus_level":"medium","plddt":94.5448,"start":61,"end":151},{"cath_id":"3.40.1350,3.40.1390","chopping":"156-270","consensus_level":"medium","plddt":96.0326,"start":156,"end":270}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2V0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2V0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2V0-F1-predicted_aligned_error_v6.png","plddt_mean":93.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CDIN1","jax_strain_url":"https://www.jax.org/strain/search?query=CDIN1"},"sequence":{"accession":"Q9Y2V0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2V0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2V0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2V0"}},"corpus_meta":[{"pmid":"23716552","id":"PMC_23716552","title":"Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.","date":"2013","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23716552","citation_count":60,"is_preprint":false},{"pmid":"30836435","id":"PMC_30836435","title":"The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.","date":"2019","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/30836435","citation_count":45,"is_preprint":false},{"pmid":"31191338","id":"PMC_31191338","title":"Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.","date":"2019","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31191338","citation_count":18,"is_preprint":false},{"pmid":"35441598","id":"PMC_35441598","title":"The congenital dyserythropoieitic anemias: genetics and pathophysiology.","date":"2021","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/35441598","citation_count":16,"is_preprint":false},{"pmid":"32518175","id":"PMC_32518175","title":"Genetic and functional insights into CDA-I prevalence and pathogenesis.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32518175","citation_count":15,"is_preprint":false},{"pmid":"37532987","id":"PMC_37532987","title":"Molecular complex detection in protein interaction networks through reinforcement learning.","date":"2023","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/37532987","citation_count":15,"is_preprint":false},{"pmid":"33121234","id":"PMC_33121234","title":"Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/33121234","citation_count":15,"is_preprint":false},{"pmid":"32293259","id":"PMC_32293259","title":"Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease.","date":"2020","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32293259","citation_count":14,"is_preprint":false},{"pmid":"29901818","id":"PMC_29901818","title":"Clinical and genetic features of congenital dyserythropoietic anemia (CDA).","date":"2018","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/29901818","citation_count":14,"is_preprint":false},{"pmid":"32239177","id":"PMC_32239177","title":"A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I).","date":"2020","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32239177","citation_count":12,"is_preprint":false},{"pmid":"29031773","id":"PMC_29031773","title":"Identification of CDAN1, C15ORF41 and SEC23B mutations in Chinese patients affected by congenital dyserythropoietic anemia.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29031773","citation_count":11,"is_preprint":false},{"pmid":"29049846","id":"PMC_29049846","title":"Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.","date":"2017","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29049846","citation_count":11,"is_preprint":false},{"pmid":"36919336","id":"PMC_36919336","title":"Tumor-associated macrophages-derived exo-let-7a promotes osteosarcoma metastasis via targeting C15orf41 in osteosarcoma.","date":"2023","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36919336","citation_count":8,"is_preprint":false},{"pmid":"33159567","id":"PMC_33159567","title":"Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.","date":"2020","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/33159567","citation_count":8,"is_preprint":false},{"pmid":"29846281","id":"PMC_29846281","title":"Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.","date":"2018","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29846281","citation_count":8,"is_preprint":false},{"pmid":"38747503","id":"PMC_38747503","title":"Updates on clinical and laboratory aspects of hereditary dyserythropoietic anemias.","date":"2024","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38747503","citation_count":5,"is_preprint":false},{"pmid":"38666530","id":"PMC_38666530","title":"Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients.","date":"2024","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38666530","citation_count":5,"is_preprint":false},{"pmid":"34930369","id":"PMC_34930369","title":"MEIS2 (15q14) gene deletions in siblings with mild developmental phenotypes and bifid uvula: documentation of mosaicism in an unaffected parent.","date":"2021","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/34930369","citation_count":4,"is_preprint":false},{"pmid":"30108417","id":"PMC_30108417","title":"Structure modeling to function prediction of Uncharacterized Human Protein C15orf41.","date":"2018","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/30108417","citation_count":2,"is_preprint":false},{"pmid":"40091041","id":"PMC_40091041","title":"Mechanism of ASF1 engagement by CDAN1.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40091041","citation_count":2,"is_preprint":false},{"pmid":"41609415","id":"PMC_41609415","title":"Anemia-associated mutations disrupt the CDIN1-Codanin1 complex in inherited congenital dyserythropoietic anemia I (CDA-I) disease.","date":"2026","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41609415","citation_count":1,"is_preprint":false},{"pmid":"32848870","id":"PMC_32848870","title":"Corrigendum: Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32848870","citation_count":1,"is_preprint":false},{"pmid":"39149339","id":"PMC_39149339","title":"Mechanism of ASF1 Inhibition by CDAN1.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39149339","citation_count":1,"is_preprint":false},{"pmid":"18067082","id":"PMC_18067082","title":"[Gene screening in five Chinese families with hereditary spastic paraplegia with thin corpus callosum].","date":"2007","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18067082","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12907,"output_tokens":2635,"usd":0.039123,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9800,"output_tokens":2552,"usd":0.0564,"stage2_stop_reason":"end_turn"},"total_usd":0.095523,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"C15orf41 (CDIN1) is predicted to encode a novel restriction endonuclease that is a member of the Holliday junction resolvase family of proteins, based on detailed sequence similarity searches; homozygous missense mutations (p.L178Q and p.Y94C) in this gene cause congenital dyserythropoietic anemia type I.\",\n      \"method\": \"Whole genome sequencing, segregation analysis, and sequence similarity/structural bioinformatics\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction of endonuclease function, no in vitro enzymatic activity demonstrated; disease linkage is strong but mechanism is inferred\",\n      \"pmids\": [\"23716552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CDIN1 endogenous protein localizes predominantly to the nucleus (with some cytosolic presence). The disease-associated mutation H230P in the nuclease domain reduces gene expression and protein level, while Y94S (in the DNA binding domain) causes a slight decrease in expression. Both mutations impair erythroid differentiation in K562 cells; H230P also causes increased S-phase accumulation.\",\n      \"method\": \"Immunofluorescence (subcellular localization), western blotting (protein levels), erythroid differentiation assay in K562 cells, cell cycle analysis\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple orthogonal methods (IF, WB, functional differentiation assay, cell cycle), single lab\",\n      \"pmids\": [\"31191338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"C15orf41 (CDIN1) forms a tight, near-stoichiometric complex with Codanin-1 (CDAN1), interacting with the C-terminal region of Codanin-1. Codanin-1 appears to sequester C15orf41 in the cytoplasm (analogous to its sequestration of ASF1), and Codanin-1 stabilizes C15orf41 protein levels.\",\n      \"method\": \"Co-immunoprecipitation, in vitro biochemical characterization, immunofluorescence, western blotting\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus in vitro characterization, replicated by independent labs (Swickley et al. 2020, Olijnik et al. 2020)\",\n      \"pmids\": [\"32239177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Codanin-1 binds to and stabilizes C15orf41 (CDIN1) protein. Overexpression of Codanin-1 shifts C15orf41 localization from nucleus to cytoplasm. Phylogenetic co-loss analysis shows Codanin-1 and C15orf41 are eliminated in the exact same animal taxa, strongly suggesting a common pathway.\",\n      \"method\": \"Co-immunoprecipitation, overexpression with immunofluorescence, phylogenetic profiling analysis\",\n      \"journal\": \"BMC molecular and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus localization shift experiment plus phylogenetic profiling, single lab\",\n      \"pmids\": [\"32293259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CDIN1 and Codanin-1 form an obligate complex that is enriched in the nucleolus. C15orf41 (CDIN1) relies on Codanin-1 for its stability. This interaction was demonstrated in human cells by co-immunoprecipitation and immunofluorescence.\",\n      \"method\": \"Immunoprecipitation, immunofluorescence, western blotting\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal IP and co-localization, single lab, consistent with Shroff et al. 2020\",\n      \"pmids\": [\"32518175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CDAN1 and CDIN1 proteins are enriched in nucleoli, which are structurally and functionally abnormal in CDA-I patient-derived erythroid cells. Erythroid cells from CDA-I patients (carrying mutations in CDAN1 or CDIN1) show delayed terminal erythroid differentiation, increased proliferation, and widespread changes in chromatin accessibility.\",\n      \"method\": \"Erythroid culture system, electron microscopy (heterochromatin morphology), immunofluorescence (nucleolar localization), ATAC-seq (chromatin accessibility), flow cytometry (differentiation)\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods with patient-derived cells; single lab but comprehensive\",\n      \"pmids\": [\"33121234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Codanin-1 physically interacts with CDIN1, and this interaction is conserved; mutations in CDAN1 and CDIN1 result in CDA-I via a common mechanism, supported by Cdan1 being essential for primitive erythropoiesis in mouse models.\",\n      \"method\": \"Co-immunoprecipitation (physical interaction), mouse knockout model (Cdan1)\",\n      \"journal\": \"Current opinion in hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — physical interaction confirmed by Co-IP (citing primary data), mouse model for pathway placement; review summarizing primary experimental findings\",\n      \"pmids\": [\"35441598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDAN1 dimerizes and assembles into cytosolic complexes with CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures show that CDAN1 engages ASF1 via two B-domains and two helices that mimic histone H3 binding, thereby sequestering and inhibiting ASF1 chaperone function. One CDAN1 can recruit two ASF1 molecules. ASF1A and ASF1B have different requirements for CDAN1 engagement. CDIN1 is a component of this cytosolic complex.\",\n      \"method\": \"Single-particle cryo-EM, biochemistry (pulldown, reconstitution), structural prediction, mutagenesis\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure plus biochemical reconstitution and mutagenesis; superseded by peer-reviewed publication (PMID:40091041)\",\n      \"pmids\": [\"39149339\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CDAN1 dimerizes and assembles into cytosolic complexes containing CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures reveal CDAN1 engages ASF1 through two B-domains and two helices mimicking histone H3, occupying all known ASF1 functional binding sites to sequester and inhibit ASF1 histone chaperoning. CDIN1 is part of this cytosolic complex. ASF1A and ASF1B differ in their requirements for CDAN1 engagement.\",\n      \"method\": \"Single-particle cryo-EM, biochemical reconstitution, structural predictions, pulldowns\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with biochemical reconstitution and multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"40091041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"CDIN1 and the C-terminus of Codanin-1 form a high-affinity heterodimeric complex with equimolar stoichiometry. CDA-I-associated mutations in either CDIN1 or Codanin-1 disrupt this interaction, suggesting disruption of the CDIN1-Codanin1 complex as a molecular mechanism underlying CDA-I. The essential interacting regions of both proteins were delineated.\",\n      \"method\": \"Biophysical techniques (complementary methods for affinity measurement and stoichiometry), structural analysis, functional mutation analysis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple complementary biophysical methods in one study with disease mutant functional validation; single lab\",\n      \"pmids\": [\"41609415\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CDIN1 (C15orf41) encodes a predicted restriction endonuclease/Holliday junction resolvase that forms a high-affinity, near-stoichiometric heterodimeric complex with Codanin-1 (CDAN1) through the Codanin-1 C-terminus; Codanin-1 stabilizes CDIN1 and sequesters it in the cytoplasm as part of a larger cytosolic complex that also contains multiple copies of the histone H3-H4 chaperones ASF1A and ASF1B (which Codanin-1 inhibits by mimicking histone H3 and occupying all ASF1 binding sites); CDIN1 localizes predominantly to the nucleus and is enriched in nucleoli during erythropoiesis, and disease-associated mutations in either CDAN1 or CDIN1 disrupt the CDIN1-Codanin1 interaction and impair erythroid differentiation and chromatin organization, causing CDA-I.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CDIN1 (C15orf41) is a nuclear, nucleolus-enriched protein that functions as an obligate partner of Codanin-1 (CDAN1) in a pathway required for erythroid differentiation, and biallelic mutation of CDIN1 causes congenital dyserythropoietic anemia type I (CDA-I) [#0, #1]. Sequence and structural analysis place CDIN1 in the Holliday junction resolvase family of restriction endonucleases [#0]. CDIN1 forms a high-affinity, near-stoichiometric heterodimer with the C-terminal region of Codanin-1; this interaction stabilizes CDIN1 protein levels and governs its localization, with Codanin-1 sequestering CDIN1 within larger cytosolic complexes [#2, #9]. These complexes also contain dimeric CDAN1 and multiple copies of the histone H3-H4 chaperones ASF1A/B, which CDAN1 engages and inhibits by mimicking histone H3 and occupying all ASF1 binding sites, placing the CDIN1-Codanin-1 module within histone chaperone regulation [#8]. In patient-derived erythroid cells, CDAN1 and CDIN1 are enriched in nucleoli that are structurally abnormal, and loss of function delays terminal erythroid differentiation, increases proliferation, and broadly alters chromatin accessibility [#5]. CDA-I-associated mutations in either CDIN1 or Codanin-1 disrupt the CDIN1-Codanin-1 interaction, defining loss of this complex as the shared molecular basis of the disease [#9]. The catalytic activity predicted for CDIN1 has not been demonstrated enzymatically in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Established CDIN1 as a disease gene and assigned a predicted molecular identity, framing the question of what biochemical function underlies CDA-I.\",\n      \"evidence\": \"Whole genome sequencing with segregation analysis and sequence/structural bioinformatics identifying homozygous missense mutations\",\n      \"pmids\": [\"23716552\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Endonuclease/resolvase activity is purely computational with no in vitro enzymatic demonstration\", \"No substrate identified\", \"No mechanistic link between predicted nuclease function and erythropoiesis\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed where CDIN1 acts and that disease mutations are functionally consequential, linking the protein to erythroid differentiation and cell cycle control.\",\n      \"evidence\": \"Immunofluorescence localization, western blot of mutant protein levels, and erythroid differentiation and cell cycle assays in K562 cells\",\n      \"pmids\": [\"31191338\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting mutations to differentiation defect unresolved\", \"Single cell-line model\", \"No direct biochemical activity tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined CDIN1's primary physical partner, revealing that CDIN1 is a Codanin-1-dependent protein whose stability and localization are controlled by complex formation.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, in vitro characterization, overexpression-driven localization shifts, immunofluorescence, and phylogenetic co-loss profiling across multiple independent labs\",\n      \"pmids\": [\"32239177\", \"32293259\", \"32518175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of nucleolar enrichment not defined\", \"Whether CDIN1 has activity independent of Codanin-1 unknown\", \"Interface residues not yet mapped at this stage\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected the CDIN1-Codanin-1 complex to a cellular phenotype, showing nucleolar abnormalities and chromatin disorganization in patient erythroid cells and a common mechanism for CDAN1 and CDIN1 mutations.\",\n      \"evidence\": \"Patient-derived erythroid cultures, electron microscopy, immunofluorescence, ATAC-seq, flow cytometry, and Cdan1 mouse knockout\",\n      \"pmids\": [\"33121234\", \"35441598\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from complex loss to altered chromatin accessibility not established\", \"CDIN1-specific knockout phenotype not separated from CDAN1\", \"Direct role of CDIN1 in chromatin organization untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided the structural context placing CDIN1 within a CDAN1-ASF1 cytosolic assembly that inhibits histone chaperone function by histone H3 mimicry.\",\n      \"evidence\": \"Single-particle cryo-EM with biochemical reconstitution, pulldowns, and mutagenesis (peer-reviewed; superseding the 2024 bioRxiv preprint)\",\n      \"pmids\": [\"40091041\", \"39149339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CDIN1's structural placement and role within the assembly not resolved at atomic level\", \"Whether CDIN1 contributes to ASF1 inhibition unknown\", \"No catalytic function assigned to CDIN1 in the complex\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Quantified the CDIN1-Codanin-1 interaction and demonstrated that CDA-I mutations on either protein disrupt it, pinning the disease mechanism to loss of the heterodimer.\",\n      \"evidence\": \"Complementary biophysical affinity and stoichiometry measurements, structural analysis, and disease-mutant functional validation\",\n      \"pmids\": [\"41609415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream molecular event triggered by complex disruption unknown\", \"Single lab\", \"Does not establish enzymatic role of CDIN1\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The predicted endonuclease/resolvase catalytic activity of CDIN1 and its physiological substrate remain undemonstrated, leaving the link between its molecular activity and erythroid chromatin biology unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vitro nuclease activity shown\", \"No DNA or RNA substrate identified\", \"Mechanistic role of CDIN1 within the CDAN1-ASF1 complex undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 8]}\n    ],\n    \"pathway\": [],\n    \"complexes\": [\"CDIN1-Codanin-1 heterodimer\", \"CDAN1-CDIN1-ASF1A/B cytosolic complex\"],\n    \"partners\": [\"CDAN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}